qz
GSK is slashing costs by $2.5 billion to fast-track its drug pipeline

The British drugmaker beat second-quarter profit expectations and now expects to start 20 or more phase III trials in 2026 [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Monitoring LLM behavior: Drift, retries, and refusal patterns

The stochastic challengeTraditional software is predictable: Input A plus function B always equals output C. This determinism allows engineers to develop robust tests. On the other hand, generative AI [...]

Match Score: 71.78

venturebeat
Definity embeds agents inside Spark pipelines to catch failures before they reach agentic AI systems

For most data engineering teams, managing pipeline reliability often means waiting for an alert, manually tracing failures across distributed jobs and clusters, and fixing problems after they've [...]

Match Score: 53.93

Destination
Hallucinations in AI: How GSK is addressing a critical problem in drug development

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems. [...]

Match Score: 48.86

venturebeat
Structured AI data pipelines score 10.9 points below free-form code — DataFlow-Harness closes the gap

If you ask an AI coding agent to write a standalone Python script to parse a single JSON file, it will likely give you a perfect answer in seconds. But the same agent often breaks if you ask it to bui [...]

Match Score: 45.69

qz
GSK is acquiring lung cancer biotech Nuvalent in its biggest deal in over a decade

The all-cash deal, GSK's largest in more than a decade, gives the British drugmaker two late-stage lung cancer drugs under FDA review [...]

Match Score: 40.99

thenextweb
Everyone’s building a ‘GPT for cells.’ Relation’s bet is manufacturing the data to train it.

The race to build an AI “foundation model of the cell” has a fuel problem. The biological data needed to train one is scarce, messy and inconsistent. Relation Therapeutics thinks the answer is to [...]

Match Score: 40.98

venturebeat
Cerebras stock nearly doubles on day one as AI chipmaker hits $100 billion — what it means for AI infrastructure

Cerebras Systems, the Silicon Valley chipmaker that built the world's largest commercial AI processor, erupted onto the Nasdaq on Wednesday, opening at $350 per share — nearly double its $185 I [...]

Match Score: 37.50

venturebeat
Grok 4.1 Fast's compelling dev access and Agent Tools API overshadowed by Musk glazing

Elon Musk's frontier generative AI startup xAI formally opened developer access to its Grok 4.1 Fast models last night and introduced a new Agent Tools API—but the technical milestones were imm [...]

Match Score: 37.48

venturebeat
One AI module faked 86% of a pipeline's accuracy gains by feeding another the answers

A retrieval-augmented generation (RAG) system is built to answer strictly from the documents it retrieves. But when engineers optimize these AI pipelines end-to-end, the reader module can learn a shor [...]

Match Score: 36.14